Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease

Table 1 Clinical characteristics of patients

	Control	CD intact	CD inflamed
n	10	10	10
Age	8.75 ± 2.36	12.4 ± 1.52	12.11 ± 1.63
Gender	2f/8m	5f/5m	2f/8m
BMI (kg/m2)	20.07 ± 2.64	14.83 ± 0.8	18.64 ± 1.81
PCDAI	0	21.94 ± 4.37c	16.11 ± 3.51b
Iron (μmol/L)	15.83 ± 2.53	4.89 ± 0.84b	8.33 ± 2.61a
TIBC (μmol/L)	60.4 ± 2.71	48.5 ± 2.64	59.71 ± 8.70
Albumin (g/L)	47.33 ± 1.31	38.67 ± 1.62	48.4 ± 5.56
Hemoglobin (g/L)	132.8 ± 6.72	113.1 ± 4.02a	124.4 ± 5.93
Hematocrit (%)	0.38 ± 0.02	0.344 ± 0.01	0.37 ± 0.02
Platelet count (Giga/L)	365.5 ± 30.29	517.1 ± 34.62a	416.7 ± 63.77

^aP≤ 0.05,

^bP≤ 0.01,

^cP≤ 0.001 vs Control. BMI: Body mass index; CD: Crohn’s disease; PCDAI: Pediatric Crohn’s disease activity index; TIBC: Total iron binding capacity.